세계의 암치료를 위한 표적 알파 치료 시장

This report provides an overview of the global market for targeted alpha therapies for cancer and analyzes market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025, forecasted CAGRs through 2030.

Report Scope

The report provides an overview of the global market for targeted alpha therapies (TAT) for cancer and analyzes market trends. It includes global revenue ($ million) for the base year data 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented based on cancer type.

The report focuses on trends and challenges that affect the market and vendor landscape. It analyzes corporate environmental, social and governance (ESG) developments and discusses emerging technologies related to the market. The report includes an analysis of the competitive landscape and pipeline analysis. A section dedicated to company profiles addresses key financials, product portfolios and recent developments involving industry leaders.

Report Includes

• Overview and an analysis of the global market for targeted alpha therapies (TAT) for cancer treatment
• Analyses of the global market trends, with historical market revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
• Estimates of the current market size and revenue prospects of the global market, accompanied by a market share analysis by cancer type and region
• Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
• Insights derived from Porter's Five Forces model, and information on emerging trends and technologies, latest developments, and product pipeline analysis
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• A relevant patent analysis, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
• Profiles of the leading companies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Overview
• Macroeconomic Factors Analysis
• Demographic Factors
• Geopolitical Factors
• Impact of the U.S. Tariff Laws
• Porter's Five Forces Analysis
• Potential of New Entrants: Moderate to Low
• Bargaining Power of Suppliers: High
• Bargaining Power of Buyers: Moderate
• Threat of Substitute Products or Services: Moderate
• Industry Competition: Low
• Value Chain Analysis

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increased Prevalence of Cancer
• Demand for Precision Medicine
• Unmet Treatment Need in Oncology
• Increased Strategic Initiatives
• Market Restraints
• Supply Chain and Manufacturing Issues
• Regulatory Hurdles
• Market Challenges
• Dosimetry Calculations
• Recoil Effect
• Market Opportunities
• New Targets
• Combination Therapies

Chapter 4 Regulatory Landscape

• Regulatory Scenario
• The U.S.
• European Union
• Japan

Chapter 5 Emerging Technologiesand Developments

• Emerging Technologies
• Advances in Drug Delivery Strategies
• Theranostics
• Pipeline Analysis
• Key Takeaways

Chapter 6 Market Segmentation Analysis

• Overview
• Segmentation Breakdown
• Market Analysis by Cancer Type
• Key Takeaways
• Prostate Cancer
• Neuroendocrine Tumors
• Other Cancers
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Market Analysis
• Strategic Initiatives
• Agreements, Collaborations and Partnerships
• Acquisitions
• Other Strategies

Chapter 8 Sustainability in Targeted Alpha Therapies for Cancer Treatment Market: An ESG Perspective

• Introduction to ESG
• Sustainability in the Targeted Alpha Therapies Industry
• ESG Performance Analysis
• Environmental Initiatives
• Social Initiatives
• Governance Initiatives
• ESG Risk Ratings
• Conclusion

Chapter 9 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• ACTINIUM PHARMACEUTICALS INC.
• ADVANCELL PTY LTD.
• BAYER AG
• CONVERGENT THERAPEUTICS INC.
• FUSION PHARM
• NOVARTIS AG
• ORANO MED
• PERSPECTIVE THERAPEUTICS
• RADIOMEDIX INC.
• RAYZEBIO INC.
• Emerging Startups in the Market